Acquisitionrmcs

Acquisitionrmcs@va.gov serves as the primary contracting representative for the VA Risk Management and Compliance Service under the 255-NETWORK Contract Office 15 (36C255), overseeing the procurement of critical healthcare infrastructure and medical support systems essential to veteran care delivery. This role is central to the Department of Veterans Affairs’ mission of modernizing clinical environments and ensuring operational readiness across VA medical facilities. The individual manages a portfolio of acquisitions focused on pharmaceutical preparation manufacturing, facility upgrades, and technical systems that support diagnostic and surgical capabilities, ensuring compliance with federal procurement regulations and VA-specific clinical standards. Contractor relationships are primarily established with specialized firms such as JETT’S SPECIALTY CONTRACTING, LLC, MCKENZIE CONSTRUCTION & SITE DEVELOPMENT LLC, HIGHLANDS DEVELOPMENT LLC, RISE COMPANIES, LLC, and MEDICONE MEDICAL RESPONSE OF TENNESSEE, INC. These partnerships reflect a preference for contractors with demonstrated expertise in medical facility construction, equipment installation, and emergency medical response logistics. The working relationship pattern emphasizes performance-based contracting, rigorous compliance oversight, and delivery of mission-critical services under tight operational timelines. There is no preference for socioeconomic set-asides; all procurements are conducted as full and open competitions, reflecting a strategic focus on technical capability and operational readiness over socioeconomic targeting. This approach ensures access to the broadest possible pool of qualified vendors capable of meeting the high standards of VA healthcare infrastructure. The primary NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing), indicating a deep specialization in the procurement of sterile pharmaceuticals, compounded medications, and related production systems. The individual possesses technical expertise in Good Manufacturing Practices (GMP), aseptic processing, and FDA-regulated medical supply chains, ensuring that all acquired products meet stringent clinical and regulatory requirements for veteran use.